Key facts
- This page summarizes Robert E. Landry's Form 4 filing for Zymeworks Inc. (ZYME).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2026, 20:56.
Robert E. Landry - 12 Jan 2026 Form 4 Insider Report for Zymeworks Inc. (ZYME)
- Reporting relationship
- Director
- Issuer ticker
- ZYME
- Reported as of
- 12 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2026, 20:56:39 UTC
- Prior SEC filing
- 12 Aug 2025
- Next SEC filing
- 27 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Dex, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert E. Landry filed Form 4 for Zymeworks Inc. (ZYME) on 12 Jan 2026.
Change
- Previous filing in this sequence was filed on 12 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001585160
Primary reporting owner
Landry Robert E
- Relationship
- Director
- Address
- C/O ZYMEWORKS INC., 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN
- Signature
- /s/ Daniel Dex, Attorney-in-Fact
- Signature date
- 12 Jan 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZYME
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +11,500
- Change %
- Price
- $0.000000
- Shares after
- 11,500
- Date
- 12 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,500
- Exercise price
- $23.16
- Footnotes
- F1
ZYME
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +7,700
- Change %
- Price
- $0.000000
- Shares after
- 7,700
- Date
- 12 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,700
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Stock options vest on January 12, 2027.
Footnote F2
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of common stock.
Footnote F3
RSUs vest on January 12, 2027.